China Meheco Wins Performance Compensation Dispute Involving Subsidiary

MT Newswires Live
Sep 09

China Meheco (SHA:600056) received a court-mandated enforcement payment from shareholder Tibet Tiansheng related to performance compensation involving subsidiary Henan General Pharmaceutical, according to a Wednesday filing with the Shanghai bourse.

The drug company received 101.2 million yuan in principal and interest from Tibet Tiansheng, while Henan General received 5 million yuan directly from the shareholder, the filing said.

Meheco offset about 16.9 million yuan of its own debt to Tibet Tiansheng, the filing said.

Meheco filed a lawsuit against Tibet Tiansheng regarding a performance compensation dispute related to Henan General in October 2024. An intermediate court in Beijing ruled with finality in favor of Meheco following appeals by the shareholder.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10